Profile data is unavailable for this security.
About the company
CanSino Biologics Inc is a China-based company primarily engaged in the research and development, production, and commercialization of human vaccine products. The Company’s products and product pipeline under research include multiple vaccine varieties such as meningitis, pneumonia, diphtheria, tetanus, and pertussis (DPT), coronavirus disease 2019 (COVID-19), Ebola virus disease, poliomyelitis, herpes zoster, tuberculosis and others. The Company is also engaged in the research and development of pharmaceutical production processes. The Company conducts its business in the domestic and overseas markets.
- Revenue in HKD (TTM)1.04bn
- Net income in HKD-189.78m
- Incorporated2009
- Employees1.11k
- LocationCanSino Biologics IncWest District Biomedical Park, No. 185South Avenue, West District, EconomicTIANJIN 300457ChinaCHN
- Phone+86 2 258213766
- Fax+86 2 258213626
- Websitehttps://www.cansinotech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CStone Pharmaceuticals | 230.11m | -428.53m | 9.24bn | 93.00 | -- | 23.86 | -- | 40.15 | -0.3288 | -0.3288 | 0.1776 | 0.2624 | 0.1487 | 1.38 | 1.68 | 1,704,542.00 | -27.69 | -39.13 | -54.45 | -60.19 | -12.18 | 66.69 | -186.23 | -170.86 | 1.20 | -29.83 | 0.554 | -- | -12.21 | -- | 75.16 | -- | -- | -- |
| Luye Pharma Group Ltd | 7.01bn | 451.08m | 9.67bn | 5.12k | 20.18 | 0.5452 | 6.01 | 1.38 | 0.1199 | 0.1199 | 1.86 | 4.44 | 0.2083 | 2.42 | 2.37 | 1,361,039.00 | 1.91 | 1.98 | 3.26 | 3.16 | 66.85 | 68.37 | 9.15 | 8.04 | 1.24 | 2.35 | 0.4227 | 0.00 | -1.33 | -0.9503 | -11.40 | -19.50 | -10.95 | -- |
| China Traditional Chinese Med Hldg CoLtd | 17.71bn | -300.96m | 9.77bn | 15.58k | -- | 0.4152 | 10.70 | 0.5515 | -0.0598 | -0.0598 | 3.52 | 4.67 | 0.4326 | 1.59 | 1.71 | 1,057,360.00 | -0.93 | 3.48 | -1.42 | 5.24 | 47.66 | 54.69 | -2.15 | 7.39 | 1.51 | 9.55 | 0.1333 | 21.27 | -8.90 | 2.89 | -95.79 | -49.14 | -15.28 | -48.82 |
| Hbm Holdings Ltd | 904.99m | 571.49m | 9.91bn | 210.00 | 15.38 | 4.09 | 16.57 | 10.95 | 0.741 | 0.741 | 1.15 | 2.79 | 0.3856 | 6.32 | 32.64 | 5,801,203.00 | 24.77 | -42.87 | 30.77 | -53.24 | 92.95 | 96.12 | 64.25 | -292.58 | 6.02 | 28.63 | 0.1857 | -- | -57.43 | 47.71 | -87.81 | -- | -55.31 | -- |
| Guangzhou Innogen Pharmaceutl Grp Co Ltd | -100.00bn | -100.00bn | 11.24bn | 105.00 | -- | 13.17 | -- | -- | -- | -- | -- | 1.85 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.39 | -- | 0.0769 | -- | -- | -- | 76.18 | -- | -- | -- |
| Fujian Haixi Pharmaceuticals Co Ltd | -100.00bn | -100.00bn | 11.41bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 47.39 | -- | 15.86 | -- | -- | -- |
| Everest Medicines Ltd | 967.41m | -748.61m | 11.98bn | 722.00 | -- | 2.49 | -- | 12.38 | -2.32 | -2.32 | 2.99 | 13.62 | 0.1684 | 13.97 | 3.04 | 1,454,751.00 | -13.03 | -29.28 | -14.21 | -31.67 | 69.92 | -- | -77.38 | -1,040.86 | 5.43 | -- | 0.1577 | -- | 461.16 | -- | -23.32 | -- | 16.96 | -- |
| Sihuan Pharmaceutical Holdings Group Ltd | 2.38bn | -91.63m | 12.80bn | 2.77k | -- | 2.58 | -- | 5.37 | -0.0098 | -0.0098 | 0.2583 | 0.542 | 0.1894 | 1.49 | 3.86 | 893,796.30 | -3.05 | -3.60 | -5.01 | -5.05 | 66.29 | 73.13 | -16.08 | -19.74 | 1.61 | -1.36 | 0.1606 | -- | 2.18 | -7.96 | -301.10 | -- | -20.58 | 3.60 |
| Cansino Biologics Inc | 1.04bn | -189.78m | 13.20bn | 1.11k | -- | 1.41 | 730.62 | 12.71 | -0.7686 | -0.7686 | 4.20 | 22.56 | 0.1154 | 0.6552 | 1.45 | 939,521.60 | -2.11 | -4.08 | -2.74 | -5.40 | 75.52 | 38.74 | -18.28 | -27.69 | 2.28 | -- | 0.2781 | -- | 138.97 | -- | 74.45 | -- | 31.37 | -- |
| Consun Pharmaceutical Group Ltd | 3.71bn | 1.15bn | 14.22bn | 3.07k | 12.65 | 2.91 | 11.63 | 3.83 | 1.34 | 1.34 | 4.33 | 5.80 | 0.5642 | 2.35 | 12.33 | 1,173,505.00 | 17.60 | 14.71 | 24.67 | 22.82 | 76.62 | 75.04 | 31.20 | 29.56 | 3.32 | -- | 0.0517 | 40.93 | 14.56 | 11.42 | 16.05 | 62.72 | -9.54 | 25.83 |
| Ascletis Pharma Inc | 2.69m | -293.84m | 15.30bn | 208.00 | -- | 6.55 | -- | 5,695.75 | -0.3004 | -0.3004 | 0.0028 | 2.20 | 0.0011 | 0.2668 | 11.59 | 11,629.77 | -12.10 | -8.46 | -12.73 | -8.80 | 36.21 | 7.91 | -10,937.78 | -522.12 | 14.53 | -- | 0.0023 | -- | -97.73 | -62.52 | -107.95 | -- | -40.26 | -- |
| CF PharmTech Inc | 686.31m | 31.54m | 15.42bn | 574.00 | 489.55 | 14.17 | 149.63 | 22.47 | 0.0766 | 0.0766 | 1.67 | 2.64 | -- | -- | -- | -- | -- | -- | -- | -- | 80.18 | -- | 4.60 | -- | 1.89 | -- | 0.076 | -- | 9.23 | -- | -33.53 | -- | -- | -- |
| Zai Lab Ltd | 3.60bn | -1.37bn | 15.44bn | 1.78k | -- | 2.71 | -- | 4.29 | -1.25 | -1.25 | 3.29 | 5.06 | 0.3903 | 3.12 | 4.81 | -- | -14.89 | -30.44 | -21.37 | -36.84 | 61.15 | 63.11 | -38.15 | -128.85 | 2.27 | -- | 0.2223 | -- | 15.33 | 56.54 | 31.73 | -- | 4.70 | -- |
| Vigonvita Life Sciences Co Ltd | -100.00bn | -100.00bn | 16.58bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -94.07 | -- | -1,848.73 | -- | -- | -- |
Data as of Mar 05 2026. Currency figures normalised to CanSino Biologics Inc's reporting currency: Hong Kong Dollar HKD
8.13%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 04 Feb 2026 | 3.43m | 2.58% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 1.82m | 1.37% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 1.07m | 0.81% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 1.02m | 0.77% |
| Capital Research & Management Co. (World Investors)as of 31 Dec 2025 | 864.52k | 0.65% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 614.40k | 0.46% |
| Fullgoal Asset Management (HK) Ltd.as of 30 Jun 2025 | 583.20k | 0.44% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 494.20k | 0.37% |
| BlackRock Advisors (UK) Ltd.as of 06 Feb 2026 | 454.00k | 0.34% |
| BlackRock Investment Management (UK) Ltd.as of 31 Jan 2026 | 446.00k | 0.34% |
More ▼
Data from 30 Jun 2025 - 12 Feb 2026Source: FactSet Research Systems Inc.
